Niren Angle, MD
Vascular Surgery · Laguna Hills, CANPI 1720045412
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $9,500 of the $12,340 with a category attached, or 77.0%. 20 manufacturers reported payments, led by Abbott at 54.2% of the total. Reporting peaked in 2019 at $7,767 and has fallen 88.7% since, to $877 in 2025.
Across 87 payments — averaging $141.84 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$7K
- Applied Medical Resources Corporation$2K
- Boston Scientific$1K
- Shockwave Medical, Inc$846
- Cvrx, Inc.$392
- Reflow Medical Inc$238
- plus $878 from 14 others
What the payments were for
- Consulting fees$9,50077%
- Food & beverage$2,84023%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 18 | $6,689 |
| Applied Medical Resources Corporation | 3 | $2,250 |
| Boston Scientific | 3 | $1,048 |
| Shockwave Medical, Inc | 26 | $846 |
| Cvrx, Inc. | 5 | $392 |
| Reflow Medical Inc | 9 | $238 |
| Inari Medical, Inc. | 3 | $200 |
| Medtronic | 1 | $171 |
| Silk Road Medical, Inc. | 1 | $156 |
| Bard Peripheral Vascular, Inc. | 6 | $111 |
| Atricure, Inc. | 2 | $62 |
| Venclose Inc. | 2 | $41 |
| Mozarc Medical US LLC | 1 | $20 |
| Cardiovascular Systems Inc. | 1 | $20 |
| BD | 1 | $19 |
| Johnson & Johnson | 1 | $19 |
| Penumbra, Inc. | 1 | $17 |
| Bard Access Systems, Inc. | 1 | $17 |
| Abiomed | 1 | $14 |
| Philips North America LLC | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Omnilink Elite vascular stent system$6,350
- WALLSTENT$900
- GENERAL CATHETERS$900
- ANGIOJET$900
- Vascular Lithotripsy$324
- ENROUTE Transcarotid Neuroprotection System$311
- Barostim Neo System$298
- Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter$198
- ENDURANT IIS$171
- ENROUTE Enflate Transcarotid RX Balloon Dilatation Catheter$156
- ENROUTE Transcarotid Stent$156
- ELUVIA$145
How this compares
$12,340 in reported general payments places this provider in the 75th percentile of 519 vascular surgery providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 24 | $30,101 |
| ClopidogrelClopidogrel Bisulfate | 60 | $396 |
Paid to pharmacies, not to this prescriber.
Other vascular surgery in Laguna Hills
- Wang TengLaguna Hills$37K
- Son DuongFountain Valley$503K
- Venita ChandraPalo Alto$488K
- Sukgu HanLos Angeles$477K
- Leigh Ann ObanionFresno$469K
- Trevor DerderianRancho Mirage$359K
- Karthikeshwar KasirajanPalo Alto$349K
- Johnathon RolloLos Angeles$337K
- Melissa LojaFairfield$272K
- Jason LeePalo Alto$228K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.